Concomitant Discontinuation of Cardiovascular Therapy and Adjuvant Hormone Therapy Among Patients With Breast Cancer

IMPORTANCE: A large proportion of patients with breast cancer concomitantly use adjuvant hormone therapy and cardiovascular therapy. OBJECTIVE: To examine the relative risk of discontinuing cardiovascular therapy during the periods before and after discontinuation of adjuvant hormone therapy. DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Zeng, Erwei, Sjölander, Arvid, Hübbert, Laila, Hedayati, Elham, Czene, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352860/
https://www.ncbi.nlm.nih.gov/pubmed/37459096
http://dx.doi.org/10.1001/jamanetworkopen.2023.23752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352860/
https://www.ncbi.nlm.nih.gov/pubmed/37459096
http://dx.doi.org/10.1001/jamanetworkopen.2023.23752

Ejemplares similares